BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 1750431)

  • 1. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
    Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
    Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of systemic mast cell disease with associated hematologic disorders.
    Travis WD; Li CY; Yam LT; Bergstralh EJ; Swee RG
    Cancer; 1988 Sep; 62(5):965-72. PubMed ID: 3409177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic aspects of systemic mastocytosis.
    Parker RI
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):557-68. PubMed ID: 10909040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
    Stevens EC; Rosenthal NS
    Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study.
    Pardanani A; Baek JY; Li CY; Butterfield JH; Tefferi A
    Mayo Clin Proc; 2002 Nov; 77(11):1169-75. PubMed ID: 12440552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy in the management of systemic mast cell disease.
    Friedman B; Darling G; Norton J; Hamby L; Metcalfe D
    Surgery; 1990 Jan; 107(1):94-100. PubMed ID: 2404352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic mast cell disease. Analysis of 58 cases and literature review.
    Travis WD; Li CY; Bergstralh EJ; Yam LT; Swee RG
    Medicine (Baltimore); 1988 Nov; 67(6):345-68. PubMed ID: 3054417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow angiogenesis in systemic mast cell disease.
    Baek JY; Li CY; Pardanani A; Butterfield JH; Tefferi A
    J Hematother Stem Cell Res; 2002 Feb; 11(1):139-46. PubMed ID: 11847010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolent systemic mast cell disease: immunophenotypic characterization of bone marrow mast cells by flow cytometry.
    Bodni RA; Sapia S; Galeano A; Kaminsky A
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):160-6. PubMed ID: 12705744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic mastocytosis and secondary acute myeloid leukemia].
    Galán Alvarez P; Ibáñez García J; Funes Vera C; López García-Carreño MD; Alix Trueba A; Pérez Guillermo M; Alberola C
    An Med Interna; 1999 Sep; 16(9):466-8. PubMed ID: 10609361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3):47S-51S. PubMed ID: 2002263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of mast cells in myeloproliferative disorders and myelodysplastic syndromes.
    Dunphy CH
    Arch Pathol Lab Med; 2005 Feb; 129(2):219-22. PubMed ID: 15679425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):47S-51S; discussion 50S, 60S-65S. PubMed ID: 16799609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic mast cell disease: a clinical and hematopathologic study of 26 cases.
    Webb TA; Li CY; Yam LT
    Cancer; 1982 Mar; 49(5):927-38. PubMed ID: 6174198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
    Horny HP; Ruck P; Kröber S; Kaiserling E
    Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3):52S-53S; discussion 53S-54S. PubMed ID: 2002265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications.
    Escribano L; Orfao A; Díaz-Agustin B; Villarrubia J; Cerveró C; López A; Marcos MA; Bellas C; Fernández-Cañadas S; Cuevas M; Sánchez A; Velasco JL; Navarro JL; Miguel JF
    Blood; 1998 Apr; 91(8):2731-6. PubMed ID: 9531582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow findings in systemic mastocytosis.
    Horny HP; Parwaresch MR; Lennert K
    Hum Pathol; 1985 Aug; 16(8):808-14. PubMed ID: 3860469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic mast cell disease associated with the hypereosinophilic syndrome.
    McElroy EA; Phyliky RL; Li CY
    Mayo Clin Proc; 1998 Jan; 73(1):47-50. PubMed ID: 9443678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.